Key result
Cigarette smoking is linked to delayed diagnosis and worse PAH prognosis, particularly in males.
Why the study?
Does cigarette smoking affect the diagnosis and survival of patients with PAH and CTEPH?
Observational
Yes
Does cigarette smoking affect the diagnosis and survival of patients with PAH and CTEPH?
Cigarette smoking is associated with delayed diagnosis and worse survival in male patients with PAH, highlighting the importance of smoking history in the prognosis of pulmonary arterial hypertension.
Answers are grounded in this paper and cite their sources.
Prompts targeted risk assessment and earlier PAH diagnosis in male ever-smokers; hypothesis-generating for sex-specific effects.
BACKGROUND: Exposure to cigarette smoke is a risk factor for endothelial dysfunction, leading to alterations in pulmonary vascular architecture and contributing to the development of pulmonary hypertension. Despite this evidence, the impact of smoking on pulmonary arterial hypertension (PAH) has only recently gained recognition. RESEARCH QUESTION: The primary objective of this study was to further investigate the influence of cigarette smoking on the diagnosis and progression of patients with PAH and chronic thromboembolic pulmonary hypertension (CTEPH). STUDY DESIGN AND METHODS: We assessed the prevalence of cigarette smoking and analysed the demographics and clinical outcomes of ever-smokers versus never-smokers included in the Spanish Registry of Pulmonary Arterial Hypertension (REHAP). RESULTS: = 201) of those with CTEPH. In PAH patients, ever-smokers were significantly older at diagnosis and study enrolment compared to never-smokers. Notably, a poorer clinical course was observed in male PAH patients who were ever-smokers, with a statistically significant association. In contrast, no significant differences in survival rates were detected between ever-smokers and never-smokers with CTEPH. CONCLUSION: Cigarette smoking is associated with delayed diagnosis and worse survival outcomes in PAH but not in CTEPH. Male ever-smokers patients with PAH has worse prognosis than female ever-smokers. Further research is warranted to elucidate the underlying mechanisms contributing to the negative correlation between smoking and PAH.
No takes yet. Share an insight, caveat, or question.
Khilzi et al. (2026) conducted an observational in Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Cigarette smoking vs. Never-smokers was evaluated on Diagnosis and survival outcomes. Cigarette smoking exposure was associated with delayed diagnosis and worse survival outcomes in patients with pulmonary arterial hypertension, particularly males, but not in those with CTEPH.
Synapse has enriched 10 related papers. Consider them for comparative context: